Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database

Bone Marrow Transplant. 2017 Aug;52(8):1218-1220. doi: 10.1038/bmt.2017.106. Epub 2017 Jun 5.

Authors

A Necchi¹, S Lo Vullo¹, G Rosti², M Badoglio³, P Giannatempo¹, D Raggi¹, S Secondino², L Mariani¹, F Lanza⁴, P Pedrazzoli²

Affiliations

¹ Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
² Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
³ EBMT Study Office, EBMT, Paris, France.
⁴ Hospital of Ravenna, Ravenna, Italy.

PMID: 28581469
DOI: 10.1038/bmt.2017.106

No abstract available

Publication types

Clinical Trial
Multicenter Study

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Bone Marrow Transplantation*
Databases, Factual*
Europe / epidemiology
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasms, Germ Cell and Embryonal / mortality*
Neoplasms, Germ Cell and Embryonal / therapy*
Retrospective Studies
Societies, Medical